Literature DB >> 3549356

Susceptibility of human glial cells to infection with human immunodeficiency virus (HIV).

S Dewhurst, J Bresser, M Stevenson, K Sakai, M J Evinger-Hodges, D J Volsky.   

Abstract

Three human brain-derived cell lines (including two of astrocytic origin) were exposed in vitro to the human immunodeficiency virus (HIV), the etiologic agent of immunodeficiency in AIDS. In all three lines, HIV transcripts were detected by in situ hybridisation in 20-30% of cells 48 h after infection. Synthesis of virus gag gene products p24 and p55 was demonstrated by immunoblotting. No cytopathic effects typical of HIV-infected human T lymphocytes were observed. Our data indicate that HIV is neurotropic, and support the hypothesis that this virus may infect astrocytes in the brain.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3549356     DOI: 10.1016/0014-5793(87)81479-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  29 in total

1.  Studies on human immunodeficiency virus-induced cytopathic effects: use of human rhabdomyosarcoma (RD) cells.

Authors:  A Srinivasan; C S Goldsmith; D York; R Anand; P Luciw; G Schochetman; E Palmer; C Bohan
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

2.  Persistent productive infection of human glial cells by human immunodeficiency virus (HIV) and by infectious molecular clones of HIV.

Authors:  S Dewhurst; K Sakai; J Bresser; M Stevenson; M J Evinger-Hodges; D J Volsky
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

3.  Molecular programming of endothelin-1 in HIV-infected brain: role of Tat in up-regulation of ET-1 and its inhibition by statins.

Authors:  Ashok Chauhan; Sven Hahn; Suzanne Gartner; Carlos A Pardo; Senthil Kumar Netesan; Justin McArthur; Avindra Nath
Journal:  FASEB J       Date:  2006-12-28       Impact factor: 5.191

4.  Correlation of specific virus-astrocyte interactions and cytopathic effects induced by ts1, a neurovirulent mutant of Moloney murine leukemia virus.

Authors:  E Shikova; Y C Lin; K Saha; B R Brooks; P K Wong
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

5.  Central nervous system-derived cells express a kappa B-binding activity that enhances human immunodeficiency virus type 1 transcription in vitro and facilitates TAR-independent transactivation by Tat.

Authors:  J P Taylor; R J Pomerantz; G V Raj; F Kashanchi; J N Brady; S Amini; K Khalili
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

6.  Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophages.

Authors:  B Chesebro; J Nishio; S Perryman; A Cann; W O'Brien; I S Chen; K Wehrly
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

Review 7.  Solving the Blood-Brain Barrier Challenge for the Effective Treatment of HIV Replication in the Central Nervous System.

Authors:  Luc Bertrand; Madhavan Nair; Michal Toborek
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

8.  Persistent inapparent HIV-1 infection of human neuroblastoma cells.

Authors:  M Vesanen; T Linna; A Vaheri
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

9.  Feline immunodeficiency virus decreases cell-cell communication and mitochondrial membrane potential.

Authors:  I R Danave; E Tiffany-Castiglioni; E Zenger; R Barhoumi; R C Burghardt; E W Collisson
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

10.  Failure of human immunodeficiency virus entry and infection in CD4-positive human brain and skin cells.

Authors:  B Chesebro; R Buller; J Portis; K Wehrly
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.